Billiontoone, INC

BillionToOne announced robust second quarter 2026 financial results, with a 64% year-over-year revenue increase and a shift to profitability, while reiterating full-year revenue guidance.

BillionToOne, Inc. announced the successful election of Class I directors and the ratification of its independent auditor at the 2026 Annual Meeting.

BillionToOne announced robust first quarter 2026 financial results, with an 84% revenue increase and a significant rise in gross profit margin, leading to raised full-year revenue guidance.

BillionToOne, Inc. reported robust fourth-quarter and full-year 2025 financial results, driven by significant revenue growth and improved profitability, leading to an upward revision of its 2026 revenue guidance.

BillionToOne, Inc. announced significant revenue growth of 64% year-over-year for Q2 2026, driven by increased test volumes and higher average selling prices, alongside a substantial increase in cash and cash equivalents.

BillionToOne, Inc. announces significant revenue and profit increase in Q1 2026, driven by strong test volume and ASP growth in prenatal and oncology diagnostics.

Bosch John Roderick Ten, SVP of Laboratory Operations of BillionToOne, Inc., sold 1,417 shares of common stock on August 10, 2026 for $92.86 per share.

David Tsao, Chief Technology Officer and a Director of BillionToOne, Inc., sold 10,000 shares of common stock on August 10, 2026 for $92.86 per share.

Oguzhan Atay, Chairman and CEO and a Director of BillionToOne, Inc., sold 15,539 shares of common stock on August 5, 2026 for $150.03 per share.

Oguzhan Atay, Chairman and CEO and a Director of BillionToOne, Inc., sold 45,000 shares of common stock on August 3, 2026.

Nancy Joann Johnson, See Remarks of BillionToOne, Inc., sold 14,199 shares of common stock on July 16, 2026.

Bosch John Roderick Ten, SVP of Laboratory Operations of BillionToOne, Inc., sold 4,251 shares of common stock on July 13, 2026 for $125.46 per share.

BillionToOne, Inc. has issued its 2026 proxy statement detailing the agenda for its upcoming annual meeting of stockholders to be held on June 10, 2026.

A group of NeoTribe entities and Krishna Kolluri have filed a Schedule 13G, disclosing beneficial ownership of 10.6% of BillionToOne, Inc.'s Class A Common Stock.